Gut Microbiota-mediated Pharmacokinetics of Ginseng Saponins

Overview

Journal J Ginseng Res

Date 2018 Jul 10

PMID 29983606

Citations 77

Authors

Dong-Hyun Kim

Affiliations

Soon will be listed here.

Abstract

Orally administered ginsengs come in contact with the gut microbiota, and their hydrophilic constituents, such as ginsenosides, are metabolized to hydrophobic compounds by gastric juice and gut microbiota: protopanxadiol-type ginsenosides are mainly transformed into compound K and ginsenoside Rh2; protopanaxatriol-type ginsenosides to ginsenoside Rh1 and protopanaxatriol, and ocotillol-type ginsenosides to ocotillol. Although this metabolizing activity varies between individuals, the metabolism of ginsenosides to compound K by gut microbiota in individuals treated with ginseng is proportional to the area under the blood concentration curve for compound K in their blood samples. These metabolites such as compound K exhibit potent pharmacological effects, such as antitumor, anti-inflammatory, antidiabetic, antiallergic, and neuroprotective effects compared with the parent ginsenosides, such as Rb1, Rb2, and Re. Therefore, to monitor the potent pharmacological effects of ginseng, a novel probiotic fermentation technology has been developed to produce absorbable and bioactive metabolites. Based on these findings, it is concluded that gut microbiota play an important role in the pharmacological action of orally administered ginseng, and probiotics that can replace gut microbiota can be used in the development of beneficial and bioactive ginsengs.

Citing Articles

Panax ginseng nanoemulsion for counteracting male infertility via modulating sex hormones and oxidative stress in a rat model.

El-Shimi B, Mohareb R, Ahmed H, Abohashem R, Mahmoud K, Hanna D Sci Rep. 2024; 14(1):29239.

PMID: 39587216 PMC: 11589876. DOI: 10.1038/s41598-024-79388-x.

Application of microorganisms in Panax ginseng: cultivation of plants, and biotransformation and bioactivity of key component ginsenosides.

Ji H, Guo L, Yu D, Du X Arch Microbiol. 2024; 206(11):433.

PMID: 39412649 DOI: 10.1007/s00203-024-04144-8.

Enhanced Minor Ginsenoside Contents of Nano-Sized Black Korean Ginseng through Hot Melt Extrusion.

Lee J, Lee H, Baek J Materials (Basel). 2024; 17(18).

PMID: 39336353 PMC: 11433342. DOI: 10.3390/ma17184612.

In vivo pharmacokinetics of ginsenoside compound K mediated by gut microbiota.

Deng M, Huang S, Xu Y, Shao L, Wang Z, Chen L PLoS One. 2024; 19(8):e0307286.

PMID: 39178246 PMC: 11343376. DOI: 10.1371/journal.pone.0307286.

Microbiota, natural products, and human health: exploring interactions for therapeutic insights.

Qadri H, Shah A, Almilaibary A, Mir M Front Cell Infect Microbiol. 2024; 14:1371312.

PMID: 39035357 PMC: 11257994. DOI: 10.3389/fcimb.2024.1371312.

References

Bae E, Shin J, Kim D . Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol Pharm Bull. 2005; 28(10):1903-8. DOI: 10.1248/bpb.28.1903. View

Dominguez-Bello M, Costello E, Contreras M, Magris M, Hidalgo G, Fierer N . Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010; 107(26):11971-5. PMC: 2900693. DOI: 10.1073/pnas.1002601107. View

Cui J, Bjorkhem I, Eneroth P . Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations. J Chromatogr B Biomed Sci Appl. 1997; 689(2):349-55. DOI: 10.1016/s0378-4347(96)00304-0. View

Matsuda H, Namba K, Fukuda S, Tani T, Kubo M . Pharmacological study on Panax ginseng C. A. Meyer. IV. Effects of red ginseng on experimental disseminated intravascular coagulation. (3). Effect of ginsenoside-Ro on the blood coagulative and fibrinolytic system. Chem Pharm Bull (Tokyo). 1986; 34(5):2100-4. DOI: 10.1248/cpb.34.2100. View

Kim D . Gut Microbiota-Mediated Drug-Antibiotic Interactions. Drug Metab Dispos. 2015; 43(10):1581-9. DOI: 10.1124/dmd.115.063867. View

Hasegawa H, Sung J, MATSUMIYA S, Uchiyama M . Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 1996; 62(5):453-7. DOI: 10.1055/s-2006-957938. View

Tatsuka M, Maeda M, Ota T . Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2). Jpn J Cancer Res. 2001; 92(11):1184-9. PMC: 5926664. DOI: 10.1111/j.1349-7006.2001.tb02138.x. View

Ruan C, Liu Z, Li X, Liu X, Wang L, Pan H . Isolation and characterization of a new ginsenoside from the fresh root of Panax Ginseng. Molecules. 2010; 15(4):2319-25. PMC: 6257298. DOI: 10.3390/molecules15042319. View

Wakabayashi C, Hasegawa H, Murata J, Saiki I . In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res. 1997; 9(8):411-7. View

10.

Shibata S . Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci. 2001; 16 Suppl:S28-37. PMC: 3202208. DOI: 10.3346/jkms.2001.16.S.S28. View

11.

Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit A . The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008; 363(1-2):1-25. DOI: 10.1016/j.ijpharm.2008.07.009. View

12.

Kim D, Chang Y, Zedk U, Zhao P, Liu Y, Yang C . Dammarane saponins from Panax ginseng. Phytochemistry. 1995; 40(5):1493-7. DOI: 10.1016/0031-9422(95)00218-v. View

13.

Taniyasu S, Tanaka O, Yang T, Zhou J . Dammarane saponins of flower buds of Panax notoginseng (Sanchi-Ginseng). Planta Med. 1982; 44(2):124-5. DOI: 10.1055/s-2007-971420. View

14.

Lee S, Jeong J, Van Le T, Eun S, Nguyen M, Park J . Ocotillol, a Majonoside R2 Metabolite, Ameliorates 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis in Mice by Restoring the Balance of Th17/Treg Cells. J Agric Food Chem. 2015; 63(31):7024-31. DOI: 10.1021/acs.jafc.5b02183. View

15.

Choo M, Sakurai H, Kim D, Saiki I . A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling in murine colon cancer cells. Oncol Rep. 2008; 19(3):595-600. View

16.

Strombom J, Sandberg F, Dencker L . Studies on absorption and distribution of ginsenoside Rg-1 by whole-body autoradiography and chromatography. Acta Pharm Suec. 1985; 22(3):113-22. View

17.

Karikura M, Miyase T, Tanizawa H, Takino Y, Taniyama T, Hayashi T . Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats. Chem Pharm Bull (Tokyo). 1990; 38(10):2859-61. DOI: 10.1248/cpb.38.2859. View

18.

Bae E, Joo Han M, Kim E, Kim D . Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res. 2004; 27(1):61-7. DOI: 10.1007/BF02980048. View

19.

Akao T, Kida H, Kanaoka M, Hattori M, KOBASHI K . Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol. 1998; 50(10):1155-60. DOI: 10.1111/j.2042-7158.1998.tb03327.x. View

20.

Zhu G, Li Y, Hau D, Jiang Z, Yu Z, Fong W . Protopanaxatriol-type ginsenosides from the root of Panax ginseng. J Agric Food Chem. 2010; 59(1):200-5. DOI: 10.1021/jf1037932. View